Linked Data API

Show Search Form

Search Results

1522764
unstar this property registered interest false more like this
star this property date less than 2022-10-17more like thismore than 2022-10-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Voluntary Scheme for Branded Medicines Pricing and Access more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the Voluntary scheme for branded medicines pricing and access, whether her Department has made an assessment of the potential merits of an exemption from payments for new active substances from that scheme. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 64035 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-10-25more like thismore than 2022-10-25
star this property answer text <p>The Voluntary Scheme for Branded Medicines Pricing and Access includes a 36 month exemption from payments for drugs containing a new active substance, starting once the marketing authorisation has been granted. Treatment of new active substances under a future voluntary scheme is subject to negotiation.</p> more like this
star this property answering member constituency Newark more like this
star this property answering member printed Robert Jenrick more like this
star this property question first answered
less than 2022-10-25T16:47:32.28Zmore like thismore than 2022-10-25T16:47:32.28Z
star this property answering member
4320
unstar this property label Biography information for Robert Jenrick more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1521780
unstar this property registered interest false more like this
star this property date less than 2022-10-13more like thismore than 2022-10-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many medicine by presentations included within the Voluntary Patient Access Scheme have had NHS List Price increase approved by their Department since 1 January 2020; and what was the average percentage increase for any such increases. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 62789 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-11-03more like thismore than 2022-11-03
star this property answer text <p>Between 1 January 2020 and 14 October 2022, members of the Voluntary Scheme for Branded Medicines Pricing and Access have received approval for an increase to the National Health Service list price for 35 medicines, for 120 presentations. The majority of price increases have been concentrated in specific market segments particularly impacted by global cost increases in the active pharmaceutical ingredient.</p><p>Price increase requests are assessed in line with Scheme’s rules, which ensure companies cannot make excess profits by setting a return on sales target of 6% for standard price increase requests.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2022-11-03T13:28:21.187Zmore like thismore than 2022-11-03T13:28:21.187Z
star this property answering member
4423
unstar this property label Biography information for Will Quince more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1521782
unstar this property registered interest false more like this
star this property date less than 2022-10-13more like thismore than 2022-10-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans her Department has to carry out an impact assessment on the effect of an increased voluntary scheme for branded medicine rate to a projected 23.7 per cent in 2023 upon the supply of medicines to the NHS. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 62790 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-11-01more like thismore than 2022-11-01
star this property answer text <p>The Department has no plans to carry out an impact assessment on the 2023 payment percentage. The Department’s standard practice is to set the payment percentage based on measured sales. The payment percentage projected for 2023 is in line with Department projections shared with industry when the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) was agreed.</p><p>We have seen no evidence that increased VPAS payments have or will impact on the supply of medicines to the National Health Service. Where payment rates may put pressure on the profitability of individual products, there are provisions in the scheme for companies to apply for a price increase.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2022-11-01T12:16:12.963Zmore like thismore than 2022-11-01T12:16:12.963Z
star this property answering member
4423
unstar this property label Biography information for Will Quince more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1521787
unstar this property registered interest false more like this
star this property date less than 2022-10-13more like thismore than 2022-10-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if she will make it her policy to publish data comparing the voluntary scheme for branded medicines pricing and access repayments against leading European countries with similar access or rebate schemes in each year since 2015. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 62791 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-10-25more like thismore than 2022-10-25
star this property answer text <p>We have no plans to do so.</p><p>Prices paid for medicines internationally are generally confidential. It is therefore not possible to make an accurate comparison of the net price of medicines between the UK and other countries, with or without rebate rates.</p> more like this
star this property answering member constituency Newark more like this
star this property answering member printed Robert Jenrick more like this
star this property question first answered
less than 2022-10-25T14:51:43.1Zmore like thismore than 2022-10-25T14:51:43.1Z
star this property answering member
4320
unstar this property label Biography information for Robert Jenrick more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1521788
unstar this property registered interest false more like this
star this property date less than 2022-10-13more like thismore than 2022-10-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, for what reason her Department included branded (a) generic and (b) biosimilar medicines that delivered savings to the NHS within the current voluntary scheme for branded medicines pricing and access scheme. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 62792 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-11-01more like thismore than 2022-11-01
star this property answer text <p>Medicines which are required to be prescribed by brand name, including some branded generics and biosimilars, are not interchangeable. Therefore, competitive forces will not act in the same way as for generic medicines and price regulation is justified. The inclusion of these medicines in the Voluntary Scheme for Branded Medicines Pricing and Access was agreed with industry in 2019.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2022-11-01T12:23:25.943Zmore like thismore than 2022-11-01T12:23:25.943Z
star this property answering member
4423
unstar this property label Biography information for Will Quince more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1521789
unstar this property registered interest false more like this
star this property date less than 2022-10-13more like thismore than 2022-10-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if she will make a comparative estimate of the annual savings that (a) unbranded generic, (b) branded generic and (c) biosimilar medicines have contributed to the NHS drug bill compared to branded prices had those medicines not been available for each year since 2012 for which data is available. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 62793 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-10-25more like thismore than 2022-10-25
star this property answer text <p>The current Voluntary Scheme for Branded Medicines Pricing and Access expenditure forecast assumes that average spend at patent expiry will decrease by 70% for a non-biologic medicine or 45% for a biologic medicine. The Secretary of State has also commissioned further policy advice on this matter. These assumptions will be reviewed ahead of the negotiation of a new Scheme.</p> more like this
star this property answering member constituency Newark more like this
star this property answering member printed Robert Jenrick more like this
star this property question first answered
less than 2022-10-25T14:44:42Zmore like thismore than 2022-10-25T14:44:42Z
star this property answering member
4320
unstar this property label Biography information for Robert Jenrick more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1423145
unstar this property registered interest false more like this
star this property date less than 2022-02-18more like thismore than 2022-02-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Hospices: Apprentices more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department (a) has taken and (b) is planning to take to encourage hospices to access Apprenticeship Levy funding. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 125102 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-02-23more like thismore than 2022-02-23
star this property answer text <p>We are increasing funding for apprenticeships to £2.7 billion by 2024/25. This will support apprenticeships in non-levy employers, such as hospices, where the Government will continue to pay 95% of training costs.</p><p>Since 1 April 2021, all non-levy paying employers, including hospices, arranging new apprenticeships must do so through the apprenticeship service. This provides more control over apprenticeship choices and the ability to reserve funds before choosing the appropriate apprenticeship provider. All small and medium-sized enterprises, such as hospices, have been able to reserve funding for up to 10 new apprenticeships in 2021/22.</p> more like this
star this property answering member constituency Charnwood more like this
star this property answering member printed Edward Argar more like this
star this property grouped question UIN 125103 more like this
star this property question first answered
less than 2022-02-23T14:42:37.52Zmore like thismore than 2022-02-23T14:42:37.52Z
star this property answering member
4362
unstar this property label Biography information for Edward Argar more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1423146
unstar this property registered interest false more like this
star this property date less than 2022-02-18more like thismore than 2022-02-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Hospices: Apprentices more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the extent of apprenticeship opportunities in the hospice sector. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 125103 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-02-23more like thismore than 2022-02-23
star this property answer text <p>We are increasing funding for apprenticeships to £2.7 billion by 2024/25. This will support apprenticeships in non-levy employers, such as hospices, where the Government will continue to pay 95% of training costs.</p><p>Since 1 April 2021, all non-levy paying employers, including hospices, arranging new apprenticeships must do so through the apprenticeship service. This provides more control over apprenticeship choices and the ability to reserve funds before choosing the appropriate apprenticeship provider. All small and medium-sized enterprises, such as hospices, have been able to reserve funding for up to 10 new apprenticeships in 2021/22.</p> more like this
star this property answering member constituency Charnwood more like this
star this property answering member printed Edward Argar more like this
star this property grouped question UIN 125102 more like this
star this property question first answered
less than 2022-02-23T14:42:37.567Zmore like thismore than 2022-02-23T14:42:37.567Z
star this property answering member
4362
unstar this property label Biography information for Edward Argar more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1416309
unstar this property registered interest false more like this
star this property date less than 2022-01-25more like thismore than 2022-01-25
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Coronavirus: Israel more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent discussions (a) he and (b) Ministers have had with their Israeli counterparts on tackling covid-19. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 111550 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-01-31more like thismore than 2022-01-31
star this property answer text <p>We have had no recent discussions.</p> more like this
star this property answering member constituency Chichester more like this
star this property answering member printed Gillian Keegan more like this
star this property question first answered
less than 2022-01-31T14:05:41.48Zmore like thismore than 2022-01-31T14:05:41.48Z
star this property answering member
4680
unstar this property label Biography information for Gillian Keegan more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter
1388754
unstar this property registered interest false more like this
star this property date less than 2021-12-16more like thismore than 2021-12-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Coronavirus: Disease Control more like this
star this property house id 1 more like this
unstar this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent discussions he has had with his Israeli counterpart on tackling the omicron variant of covid-19. more like this
star this property tabling member constituency Harlow more like this
star this property tabling member printed
Robert Halfon more like this
star this property uin 94336 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2022-01-05more like thismore than 2022-01-05
star this property answer text <p>There have been no recent discussions on Omicron between the Health Secretary Sajid Javid and the Israeli Health Minister Nitzan Horowitz.</p> more like this
star this property answering member constituency Charnwood more like this
star this property answering member printed Edward Argar more like this
star this property question first answered
less than 2022-01-05T13:44:43.097Zmore like thismore than 2022-01-05T13:44:43.097Z
star this property answering member
4362
unstar this property label Biography information for Edward Argar more like this
star this property tabling member
3985
star this property label Biography information for Robert Halfon remove filter